enow.com Web Search

  1. Ads

    related to: weight neutral antidepressants

Search results

  1. Results from the WOW.Com Content Network
  2. These popular antidepressants cause the most weight gain ...

    www.aol.com/popular-antidepressants-cause-most...

    Lexapro, Paxil and Cymbalta carry a higher risk of packing on pounds than Zoloft, while Wellbutrin users are less likely to gain weight, according to a new study of eight popular antidepressants ...

  3. Escitalopram (Lexapro): Everything You Need to Know Before ...

    www.aol.com/escitalopram-lexapro-everything-know...

    Weight gain. In general, large-scale studies do tend to show that long-term use of antidepressants is associated with weight gain side effects. However, study data on escitalopram and weight ...

  4. How common antidepressants are linked to weight gain. The study found that the most used medications among the participant group were sertraline (Zoloft), citalopram (Celexa), and bupropion ...

  5. Agomelatine - Wikipedia

    en.wikipedia.org/wiki/Agomelatine

    Agomelatine, sold under the brand names Valdoxan and Thymanax, among others, is an atypical antidepressant most commonly used to treat major depressive disorder and generalized anxiety disorder. [8] One review found that it is as effective as other antidepressants with similar discontinuation rates overall but fewer discontinuations due to side ...

  6. List of antidepressants - Wikipedia

    en.wikipedia.org/wiki/List_of_antidepressants

    This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.

  7. Selective serotonin reuptake inhibitor - Wikipedia

    en.wikipedia.org/wiki/Selective_serotonin...

    [6] [11] The 2008 meta-analysis combined 35 clinical trials submitted to the Food and Drug Administration (FDA) before licensing of four newer antidepressants (including the SSRIs paroxetine and fluoxetine, the non-SSRI antidepressant nefazodone, and the serotonin and norepinephrine reuptake inhibitor (SNRI) venlafaxine).

  1. Ads

    related to: weight neutral antidepressants